Table:
begin	end	state
1	19	cytoplasmic
20	41	transmembrane
42	47	non-cytoplasmic
48	70	transmembrane
71	86	cytoplasmic
87	110	transmembrane
111	125	non-cytoplasmic
126	146	transmembrane
147	156	cytoplasmic
157	180	transmembrane
181	199	non-cytoplasmic
200	224	transmembrane
225	245	cytoplasmic
246	266	transmembrane
267	290	non-cytoplasmic
291	316	transmembrane
317	335	cytoplasmic
336	356	transmembrane
357	362	non-cytoplasmic
363	388	transmembrane
389	407	cytoplasmic
408	429	transmembrane
430	435	non-cytoplasmic
436	455	transmembrane
456	469	cytoplasmic

Input:
>WP_033100143.1 NCBI__GCF_000763315.1:WP_033100143.1
MNTSQEQQGQLKQSMKSRHLFMIALGGVIGTGFFLSTGFTIGQAGPLGAVLSYIIGGICM
YLIMLCLGELSVAMPSAGSFQDYTTKFIGPATGFAVGWMYWLGWAVTVALELTSIGLTMK
HWFPHVSIWVWCLIFGVVLFVVNAFSAKGFAETEFWFASIKVITIILFIILGGAAMFGFI
HLKGGEAAPYLSHFTQDGLFPNGFINVLVTMVAVNFSFQGTELIGIASGESENPQKTIPR
AIRQTVWRTILFFGLAVFVLCGLLPWKQAGVMESPFVTVLDKIGIPYDADIMNFVILTAL
LSVANSGLYATTRMLYALSKNGMASPVFGRLTKRGVPFNALILSMAIACLSLLSYKFAED
TVYMVLLSIAGMTAILAWMSIAASQFFFRRRYLAEGGKLEALHFKTPLYPVVPILAFLIN
LIALISLWFDPTQRPAIEYGIPAFILCYILYFLFFRKKSEAARLKMETK

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server